Placement-funded San José work
A$15.1m before costs was raised for feasibility, licence and environmental applications.
Infinity Metals’ five-year record moves from a capital-funded FY2021 through recurring operating and investing outflows, a PERTE-grant-expanded FY2024 balance sheet, and a sharply smaller FY2025 Group position after the San José impairment and grant return.
Reading the figures: Units are stated above each table or beside the metric. Brackets denote negative amounts. Supported nil is shown as zero; unlike reporting bases remain separately labelled.
Closing cash after the capital-funded year.
Includes A$30.228m deferred income.
Issuer-reported consolidated cash.
San José carrying-value reduction.
FY2021 was capital-funded for San José feasibility, licence and environmental work. Its reported profit was materially shaped by a A$4.888m impairment reversal of an equity-accounted investment, while share-based payments were a A$1.420m expense; it should not be read as recurring operating profitability.
Over FY2022-FY2023, recurring operating and investing outflows accompanied continued San José expenditure. The issuer attributed the FY2023 working-capital reduction to that project activity, not to a revenue transition.
The FY2024 expanded balance sheet incorporated PERTE grant-related security, restricted deposits and deferred income. Those arrangements make the headline financial position different from ordinary unrestricted operating liquidity.
A$15.1m before costs was raised for feasibility, licence and environmental applications.
An exploration permit covering the San José resource area was granted while cash funded project expenditure.
PERTE security and restricted deposits mean the enlarged asset base was not unrestricted operating liquidity.
The issuer withdrew from PERTE VEC IIa, impaired San José, and acquired Highland’s eastern Victorian licences through a cash-and-equity asset acquisition.
Cash moved from A$19.135m to A$5.130m. The FY2024 increase coincided with PERTE balances. FY2025 reported net assets of A$3.001m and liabilities of A$2.978m; tabled assets of A$5.978m is transparently calculated from those reported amounts.
The packet does not select FY2025 cash-flow subtotals. It does identify returned PERTE funds as driving working-capital decline and separately records the San José impairment.
A$ million
AI-generated presentation · values from Consolidated financial position; no missing values plotted as zero.
A$ million
AI-generated presentation · values from Consolidated financial position; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Cash and cash equivalents | 19.135 | 16.288 | 12.306 | 13.118 | 5.130 |
| Total assets (FY2025 calculated: net assets + liabilities) | 28.431 | 26.589 | 27.981 | 56.138 | 5.978 |
| Total liabilities | 1.210 | 1.307 | 0.499 | 31.593 | 2.978 |
| Net assets | 27.220 | 25.282 | 27.482 | 24.545 | 3.001 |
A$ million. FY2025 cash and net assets are issuer-reported consolidated narrative figures; its total assets is a labelled editorial calculation, not a separately reported line.
FY2024 includes PERTE grant-related balances; FY2025 reflects grant return and San José impairment.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
Operating cash flow was negative in every selected FY2021-FY2024 year. Investing was negative through FY2023 before a positive FY2024 subtotal, which is not operating performance.
Financing supplied A$20.236m in FY2021, A$0.964m in FY2022 and A$3.341m in FY2023; FY2024 is explicitly nil.
A$ million
AI-generated presentation · values from Cash-flow lanes through FY2024; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 |
|---|---|---|---|---|
| Net cash from/(used in) operating activities | (0.940) | (2.554) | (3.091) | (2.399) |
| Net cash from/(used in) investing activities | (0.789) | (1.255) | (4.218) | 3.223 |
| Net cash from financing activities | 20.236 | 0.964 | 3.341 | 0.000 |
A$ million; statutory consolidated cash-flow subtotals. The FY2024 investing inflow is not operating revenue.
No equivalent FY2025 three-lane subtotal is selected in the frozen packet.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
FY2021’s A$2.457m profit includes a A$4.888m impairment reversal of the equity-accounted investment, partially offset by A$1.420m share-based payments. It is an accounting-driven result, not evidence of recurring operating profit.
In October 2022, following €600,000 deferred consideration, the Group assumed control of TEL in an asset acquisition. Its interest remained 75% with a 25% non-controlling interest intact; the separate tables preserve the resulting shift from equity-accounted investment to consolidated deferred exploration accounting.
FY2025’s A$23.889m statutory loss was primarily associated with a A$20.284m San José impairment. The accounting reduction is not described as FY2025 cash expenditure.
The deferred exploration balance fell from A$17.731m to A$0.277m. The issuer identified permitting delays, depressed lithium pricing and market-capitalisation-to-net-assets disparity as impairment indicators; this is its disclosed basis, not an independent valuation.
A$ million
AI-generated presentation · values from Reported result and project carrying balance; no missing values plotted as zero.
A$ million
AI-generated presentation · values from San José carrying-value reset; no missing values plotted as zero.
A$ million
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Profit/(loss) for the year | 2.457 | (6.322) | (3.914) | (3.675) | (23.889) |
| Corporate and compliance expenses | (0.627) | (1.040) | (1.226) | (1.366) | (0.829) |
A$ million. FY2021 is a profit; FY2022-FY2025 are losses. Expenses retain reported negative signs.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2021 | FY2022 |
|---|---|---|
| Equity-accounted investment | 9.147 | 9.817 |
A$ million. Closing investment balance, not annual project expenditure. This is retained separately because the Group moved to control TEL in October 2022.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Deferred exploration and evaluation carrying balance | 14.489 | 17.730 | 0.277 |
A$ million. Closing carrying balance, not annual cash expenditure. The Group had assumed control of TEL before this series begins.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
A$ million
| Metric | FY2024 | FY2025 |
|---|---|---|
| Deferred exploration and evaluation additions | 2.928 | 0.504 |
| Deferred exploration impairment | 0.000 | (20.284) |
| Deferred exploration closing balance | 17.731 | 0.277 |
A$ million. Additions and impairment are annual movements; closing balance is a year-end stock.
FY2024 comparative impairment is explicitly nil in the FY2025 note.
Source: Annual-report extractions; report editions are listed once in the consolidated source registry.
San José permit and ECA milestones demonstrate administrative progression, not production, revenue or a development decision.
Highland was acquired as an asset acquisition with A$50,000 cash, shares and performance rights; it is not operating revenue.
Prepared solely from the existing year-by-year extraction datasets. No raw annual-report body, PDF, new database lookup or financial web research was used. Review is against those stored extractions, not a new independent original-document audit.
The source references in this report identify the public disclosures used and should be read with the associated section, table and reporting-period qualifications. This report paraphrases, organises and compares those disclosures for descriptive and educational purposes rather than reproducing source text.
Copyright and other rights in linked reports, company names, logos and third-party materials remain with their respective owners. MII Research does not claim affiliation with or endorsement by the company covered in this report, the ASX or cited organisations.
This report uses AI actively and extensively for evidence extraction, comparison, organisation, calculation checks, drafting, translation planning and presentation. Material claims received reasonable editorial review against cited public sources; this was not an audit, assurance engagement or independent verification. Limitations in public sources, AI systems and review may leave errors, omissions, inconsistencies or translation, classification and interpretation errors.
Any AI-generated visual accompanying this report must carry an adjacent, visible AI-generated label or caption. Such visuals are illustrative rather than source evidence and do not replace the cited annual-report text, table or section source.
This record is for general descriptive and educational information only. It is not financial-product, investment, legal, tax, technical or other professional advice; it is not a securities recommendation, valuation, target price, offer, solicitation or invitation to buy, sell or hold.
It does not consider any reader’s objectives, financial situation, needs, knowledge, experience or risk tolerance. Independently verify material information against the primary disclosures, obtain appropriate independent professional advice and do not use this record as the sole or primary basis for any decision.
Public sources are used in good faith, but no representation or warranty is made as to accuracy, completeness, reliability, currency or fitness for a particular purpose. To the maximum extent permitted by law, MII Research disclaims liability for direct, indirect, incidental, consequential, opportunity or investment loss arising from use of or reliance on this record; nothing excludes or limits liability that cannot lawfully be excluded or limited.
Report suspected errors to MII Research with the relevant report section and primary-source document and page reference so that the record can be reviewed and corrected where appropriate.